Zimmer Biomet director granted new phantom stock units

Hilado Maria Teresa reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hilado Maria Teresa reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. director Maria Teresa Hilado received a grant of 389.498 Phantom Stock Units. These units track the value of Zimmer Biomet common stock on a 1-for-1 basis but are settled in cash, not shares.

The units were accrued under the company’s Deferred Compensation Plan for Non-Employee Directors. Following this award, Hilado now holds a total of 12,983.867 Phantom Stock Units. Settlement is scheduled in ten annual cash installments after her service as a director ends.

Insider Trade Summary

Grant/Award: 389.498 shares

Grant/Award 1 txn

Insider Hilado Maria Teresa

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	389.498	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 12,983.867 contracts (Direct)

Footnotes (3)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Key Figures

Phantom Stock Units granted: 389.498 units Total Phantom Stock Units after grant: 12,983.867 units Grant price per unit: $0.0000 per unit +2 more

5 metrics

Phantom Stock Units granted 389.498 units Grant to director Maria Teresa Hilado on 2026-06-30

Total Phantom Stock Units after grant 12,983.867 units Hilado’s phantom balance following the award

Grant price per unit $0.0000 per unit Compensation-related award, no purchase price paid

Settlement structure 10 annual installments Cash payments after end of director service

Conversion ratio 1-for-1 Each Phantom Stock Unit tracks one common share’s value

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, 1-for-1, ten annual installments

4 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

1-for-1 financial

"The Conversion or Exercise Price of Derivative Security is 1-for-1."

ten annual installments financial

"Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Zimmer Biomet (ZBH) disclose about Maria Teresa Hilado’s latest Form 4?

Zimmer Biomet reported that director Maria Teresa Hilado received 389.498 Phantom Stock Units. These were accrued under the Deferred Compensation Plan for Non-Employee Directors and increase her total phantom holdings to 12,983.867 units linked to the company’s common stock value.

How many Phantom Stock Units did ZBH director Maria Teresa Hilado receive?

Maria Teresa Hilado received 389.498 Phantom Stock Units tied to Zimmer Biomet common stock. This award adds to her existing deferred balance, bringing her total phantom holdings to 12,983.867 units under the company’s non-employee director deferred compensation plan.

What are Phantom Stock Units in Zimmer Biomet’s (ZBH) director compensation?

Zimmer Biomet’s Phantom Stock Units are cash-settled awards that mirror the value of one share of common stock. Directors accrue these units under a Deferred Compensation Plan, receiving cash payments based on share value rather than actual stock delivery.

How and when will Maria Teresa Hilado’s Zimmer Biomet Phantom Stock Units be settled?

Hilado’s Phantom Stock Units will be settled in cash in ten annual installments. Payments begin within sixty days after the end of the calendar year in which her service as a Zimmer Biomet director ceases, spreading the benefit over a long post-service period.

Does the recent Form 4 for ZBH involve open-market buying or selling of shares?

The Form 4 reflects a grant of Phantom Stock Units, not open-market trades. The award was a compensation-related acquisition under Zimmer Biomet’s Deferred Compensation Plan, with units settled in cash rather than through buying or selling actual common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 05:44 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hilado Maria Teresa

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$86.65(2)	06/30/2026		A		389.498		(3)	(3)	Common Stock	389.498	$0	12,983.867	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Maria Teresa Hilado (power of attorney previously filed)	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)